| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $156K | -99.6% |
| R&D Expense | $256.4M | +16.4% |
| SG&A Expense | $79.3M | +7.0% |
| Operating Income | -$335.5M | -31.2% |
| Income Tax | $0 | — |
| Net Income | -$340.4M | -32.5% |
| EPS (Basic) | -$2.38 | -25.9% |
| EPS (Diluted) | -$2.38 | -25.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.9M | -64.3% |
| Current Assets | $528.8M | +12.2% |
| Total Assets | $821.6M | -20.9% |
| Current Liabilities | $53.7M | +11.5% |
| Total Liabilities | $154.7M | +26.6% |
| Stockholders' Equity | $666.9M | -27.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$220.5M | -19.3% |
| Capital Expenditures | $5.2M | -75.8% |
| Investing Cash Flow | $106.2M | -35.1% |
| Financing Cash Flow | $3.0M | -75.3% |
| Free Cash Flow | -$225.7M | -9.4% |